Cytokinetics Communications Grant Program

Cytokinetics is a biopharmaceutical company with a strong commitment to corporate responsibility, aiming to foster partnerships that align with its therapeutic focus and community priorities. As part of its philanthropic initiatives, Cytokinetics offers corporate contributions and charitable support to various organizations that serve the broader health ecosystem, particularly those working in areas of cardiovascular and neuromuscular disease. The Cytokinetics Communications Grant Program is an annual initiative designed to bolster the outreach and communication efforts of patient advocacy organizations focused on hypertrophic cardiomyopathy (HCM) and heart failure. Through this program, Cytokinetics awards five grants each year to organizations that seek to broaden awareness, increase community engagement, and extend their reach through critical communication strategies. Grants may be used to support new or essential marketing and communications programming, including personnel costs, tailored to the specific needs of each organization. To be eligible, applicants must be nonprofit or registered charitable entities located in the United States, Canada, Europe, or the United Kingdom, with a demonstrated focus on serving HCM or heart failure patient communities. All applicants are subject to a standard due diligence process, which includes an anti-bribery and anti-corruption review to ensure compliance with corporate integrity standards. Applications must include a detailed proposal explaining the intended use of funds, the strategic communications initiatives the grant will support, and the anticipated outcomes. Proposals are reviewed by a committee of Cytokinetics representatives who evaluate alignment with program objectives, particularly the potential for expanded outreach, improved community engagement, and overall impact. Recipients are required to submit a report detailing outcomes and impact by the end of the funding period. The next application cycle opens on September 23, 2025, with proposals due by November 3, 2025, at 5:00 PM Pacific Time. Interested applicants should prepare to access the application portal by the opening date and may contact grants@cytokinetics.com for additional information or clarification on the program.